Cargando…

Intronic regulation of SARS-CoV-2 receptor (ACE2) expression mediated by immune signaling and oxidative stress pathways

The angiotensin-converting enzyme 2 (ACE2) protein is a key catalytic regulator of the renin-angiotensin system (RAS), involved in fluid homeostasis and blood pressure modulation. ACE2 also serves as a cell-surface receptor for some coronaviruses such as SARS-CoV and SARS-CoV-2. Improved characteriz...

Descripción completa

Detalles Bibliográficos
Autores principales:	Richard, Daniel, Muthuirulan, Pushpanathan, Aguiar, Jennifer, Doxey, Andrew C., Banerjee, Arinjay, Mossman, Karen, Hirota, Jeremy, Capellini, Terence D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213013/ https://www.ncbi.nlm.nih.gov/pubmed/35756893 http://dx.doi.org/10.1016/j.isci.2022.104614

Ejemplares similares

Unraveling the Zoonotic Origin and Transmission of SARS-CoV-2
por: Banerjee, Arinjay, et al.
Publicado: (2021)

Molecular Determinants of SARS-CoV-2 Variants
por: Banerjee, Arinjay, et al.
Publicado: (2021)

Zooanthroponotic potential of SARS-CoV-2 and implications of reintroduction into human populations
por: Banerjee, Arinjay, et al.
Publicado: (2021)

Evolutionary trajectory of SARS-CoV-2 and emerging variants
por: Singh, Jalen, et al.
Publicado: (2021)

Experimental and natural evidence of SARS-CoV-2-infection-induced activation of type I interferon responses
por: Banerjee, Arinjay, et al.
Publicado: (2021)

Versatile use of bat ACE2 for cellular entry by MERS-CoV-like viruses
por: Baid, Kaushal, et al.
Publicado: (2023)

Predicting the recombination potential of severe acute respiratory syndrome coronavirus 2 and Middle East respiratory syndrome coronavirus
por: Banerjee, Arinjay, et al.
Publicado: (2020)

Lineage-specific differences and regulatory networks governing human chondrocyte development
por: Richard, Daniel, et al.
Publicado: (2023)

Gene expression and in situ protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissue
por: Aguiar, Jennifer A., et al.
Publicado: (2020)

Virus hunters: Discovering the evolutionary origins of SARS-CoV-2
por: Banerjee, Arinjay
Publicado: (2021)

Endocytosis‒Mediated Invasion and Pathogenicity of Streptococcus agalactiae in Rat Cardiomyocyte (H9C2)
por: Pooja, Sharma, et al.
Publicado: (2015)

Intranasal HD-Ad vaccine protects the upper and lower respiratory tracts of hACE2 mice against SARS-CoV-2
por: Cao, Huibi, et al.
Publicado: (2021)

Clash of the titans: interferons and SARS-CoV-2
por: Jouvenet, Nolwenn, et al.
Publicado: (2021)

Mechanisms of the Antifungal Action of Marine Metagenome-Derived Peptide, MMGP1, against Candida albicans
por: Pushpanathan, Muthuirulan, et al.
Publicado: (2013)

Antimicrobial Peptides: Versatile Biological Properties
por: Pushpanathan, Muthuirulan, et al.
Publicado: (2013)

Molecular Pathogenesis of Middle East Respiratory Syndrome (MERS) Coronavirus
por: Banerjee, Arinjay, et al.
Publicado: (2019)

Commentary: Phyllostomid bat microbiome composition is associated to host phylogeny and feeding strategies
por: Banerjee, Arinjay, et al.
Publicado: (2018)

Bat Influenza Viruses: Making a Double Agent of MHC Class II
por: Banerjee, Arinjay, et al.
Publicado: (2020)

Mycobacterium tuberculosis and SARS-CoV-2 co-infections: The knowns and unknowns
por: Chiok, Kim R., et al.
Publicado: (2023)

Bats and Coronaviruses
por: Banerjee, Arinjay, et al.
Publicado: (2019)

The developmental impacts of natural selection on human pelvic morphology
por: Young, Mariel, et al.
Publicado: (2022)

Relation of ACE2 with co-morbidity factors in SARS-CoV-2 pathogenicity
por: Santra, Dipannita, et al.
Publicado: (2023)

Binding of SARS-COV-2 (COVID-19) and SARS-COV to human ACE2: Identifying binding sites and consequences on ACE2 stiffness
por: Faisal, H.M. Nasrullah, et al.
Publicado: (2021)

Elevated Levels of Circulating DNA in Cardiovascular Disease Patients: Metagenomic Profiling of Microbiome in the Circulation
por: Dinakaran, Vasudevan, et al.
Publicado: (2014)

Soluble ACE2 in SARS-CoV-2 infection
por: Allison, Susan
Publicado: (2021)

ACE2: the molecular doorway to SARS-CoV-2
por: Medina-Enríquez, Miriam Marlene, et al.
Publicado: (2020)

Fish ACE2 is not susceptible to SARS-CoV-2
por: Xie, Shi-Zhe, et al.
Publicado: (2022)

Mechanistic insights into COVID-19 by global analysis of the SARS-CoV-2 3CL(pro) substrate degradome
por: Pablos, Isabel, et al.
Publicado: (2021)

An ace model for SARS-CoV-2 infection
por: Major, Jack, et al.
Publicado: (2020)

Novel Insights Into Immune Systems of Bats
por: Banerjee, Arinjay, et al.
Publicado: (2020)

The flexibility of ACE2 in the context of SARS-CoV-2 infection
por: Barros, E. P., et al.
Publicado: (2020)

Therapeutic Strategies for SARS-CoV-2 acting on ACE-2
por: Vitiello, A., et al.
Publicado: (2021)

Endocrine Significance of SARS-CoV-2’s Reliance on ACE2
por: Lazartigues, Eric, et al.
Publicado: (2020)

The flexibility of ACE2 in the context of SARS-CoV-2 infection
por: Barros, Emilia P., et al.
Publicado: (2021)

Oral cancer and ACE2 receptor of SARS-CoV-2
por: Martelli-Júnior, Hercílio, et al.
Publicado: (2020)

Endocrine significance of SARS-CoV-2’s Reliance on ACE2
por: Chappell, Mark C
Publicado: (2020)

ACE2, SARS-CoV-2 und RAAS-Blocker
por: Kintscher, Ulrich, et al.
Publicado: (2021)

The glycosylation in SARS-CoV-2 and its receptor ACE2
por: Gong, Yanqiu, et al.
Publicado: (2021)

ACE2-independent infection of T lymphocytes by SARS-CoV-2
por: Shen, Xu-Rui, et al.
Publicado: (2022)

ACE2-Independent Alternative Receptors for SARS-CoV-2
por: Lim, Suhyeon, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2kojp4agvcf8jqbdgsmtaaig1h